Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus
Anticancer Research · 2023
DOI: 10.21873/anticanres.16630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Yuko Nakayama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Himeji, Japan.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Hyogo Medical University, Kobe, Japan.
- Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Hyogo Medical University, Kobe, Japan; ko-takara@hyo-med.ac.jp.
Zitieren
APA
Nakayama, Y., Enomoto, D., Yamamoto, K., & Takara, K. (2023). Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus. Anticancer Research. https://doi.org/10.21873/anticanres.16630
Vancouver
Nakayama Y, Enomoto D, Yamamoto K, Takara K. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus. Anticancer Research. 2023. doi:10.21873/anticanres.16630
BibTeX
@article{Nakayama2023,
author = {Nakayama, Yuko and Enomoto, Daichi and Yamamoto, Kazuhiro and Takara, Kohji},
title = {Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16630}
}
EUVIMED